{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Prolapsus viscéral : Questions médicales les plus fréquentes",
"headline": "Prolapsus viscéral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Prolapsus viscéral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Prolapsus viscéral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Prolapsus d'organe pelvien",
"url": "https://questionsmedicales.fr/mesh/D056887",
"about": {
"@type": "MedicalCondition",
"name": "Prolapsus d'organe pelvien",
"code": {
"@type": "MedicalCode",
"code": "D056887",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.300.842.624"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Prolapsus viscéral",
"alternateName": "Visceral Prolapse",
"code": {
"@type": "MedicalCode",
"code": "D014782",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Matthew D Barber",
"url": "https://questionsmedicales.fr/author/Matthew%20D%20Barber",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hans Peter Dietz",
"url": "https://questionsmedicales.fr/author/Hans%20Peter%20Dietz",
"affiliation": {
"@type": "Organization",
"name": "University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Shannon L Wallace",
"url": "https://questionsmedicales.fr/author/Shannon%20L%20Wallace",
"affiliation": {
"@type": "Organization",
"name": "Division of Urogynecology and Pelvic Floor Disorders, Department of Subspecialty Care for Women's Health, Women's Health Institute, Cleveland Clinic Foundation, Cleveland, OH. Electronic address: wallacs8@ccf.org."
}
},
{
"@type": "Person",
"name": "Eric R Sokol",
"url": "https://questionsmedicales.fr/author/Eric%20R%20Sokol",
"affiliation": {
"@type": "Organization",
"name": "Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1.",
"datePublished": "2022-11-20",
"url": "https://questionsmedicales.fr/article/36719359",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CM9.0000000000002494"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of the non-occupational post-exposure prophylaxis (NPEP) knowledge scale among Chinese men who have sex with men.",
"datePublished": "2023-07-11",
"url": "https://questionsmedicales.fr/article/37434141",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16206-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations between self-test and pre- or post-exposure prophylaxis of HIV among men who have sex with men in China.",
"datePublished": "2022-07-02",
"url": "https://questionsmedicales.fr/article/35786144",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09564624221108038"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is non-occupational HIV Post Exposure Prophylaxis (nPEP) still used? An exploration of nPEP use since widespread availability of HIV PrEP.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35853770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09564624221116527"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study.",
"datePublished": "2024-06-06",
"url": "https://questionsmedicales.fr/article/38844855",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-024-09407-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "États anatomopathologiques",
"item": "https://questionsmedicales.fr/mesh/D020763"
},
{
"@type": "ListItem",
"position": 4,
"name": "Prolapsus",
"item": "https://questionsmedicales.fr/mesh/D011391"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prolapsus d'organe pelvien",
"item": "https://questionsmedicales.fr/mesh/D056887"
},
{
"@type": "ListItem",
"position": 6,
"name": "Prolapsus viscéral",
"item": "https://questionsmedicales.fr/mesh/D014782"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Prolapsus viscéral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Prolapsus viscéral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Prolapsus viscéral",
"description": "Comment diagnostique-t-on un prolapsus viscéral ?\nQuels tests sont utilisés pour évaluer un prolapsus ?\nQuels signes cliniques indiquent un prolapsus ?\nLe prolapsus peut-il être confondu avec d'autres conditions ?\nQuelle est l'importance de l'examen physique ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Prolapsus viscéral",
"description": "Quels sont les symptômes courants du prolapsus ?\nLe prolapsus peut-il causer des problèmes urinaires ?\nY a-t-il des symptômes digestifs associés ?\nComment le prolapsus affecte-t-il la sexualité ?\nLes symptômes varient-ils selon le type de prolapsus ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Prolapsus viscéral",
"description": "Comment prévenir le prolapsus viscéral ?\nLe tabagisme influence-t-il le prolapsus ?\nLes grossesses multiples augmentent-elles le risque ?\nL'âge joue-t-il un rôle dans le prolapsus ?\nLes activités physiques peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Prolapsus viscéral",
"description": "Quels traitements sont disponibles pour le prolapsus ?\nQuand la chirurgie est-elle recommandée ?\nLes pessaires sont-ils efficaces ?\nQuels exercices aident à traiter le prolapsus ?\nY a-t-il des traitements médicaux non chirurgicaux ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Prolapsus viscéral",
"description": "Quelles complications peuvent survenir avec un prolapsus ?\nLe prolapsus peut-il entraîner des problèmes psychologiques ?\nY a-t-il un risque de récidive après traitement ?\nComment les infections sont-elles liées au prolapsus ?\nLe prolapsus peut-il affecter la fonction intestinale ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Prolapsus viscéral",
"description": "Quels sont les principaux facteurs de risque du prolapsus ?\nLe mode de vie influence-t-il le prolapsus ?\nLes antécédents chirurgicaux sont-ils un facteur ?\nLes troubles du collagène sont-ils liés au prolapsus ?\nLe stress physique a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D014782?mesh_terms=Post-Exposure+Prophylaxis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un prolapsus viscéral ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen clinique et imageries comme l'échographie ou l'IRM."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer un prolapsus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'examen pelvien et des études urodynamiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un prolapsus ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une sensation de pesanteur ou des douleurs pelviennes peuvent indiquer un prolapsus."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il être confondu avec d'autres conditions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou des tumeurs pelviennes."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'examen physique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen physique est crucial pour évaluer la gravité et le type de prolapsus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du prolapsus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur pelvienne, incontinence et sensation de masse dans le vagin."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il causer des problèmes urinaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des difficultés à uriner ou des fuites urinaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la constipation ou des difficultés à déféquer peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment le prolapsus affecte-t-il la sexualité ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut causer des douleurs pendant les rapports sexuels et une diminution du désir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de prolapsus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'un prolapsus vaginal, rectal ou utérin."
}
},
{
"@type": "Question",
"name": "Comment prévenir le prolapsus viscéral ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, faire des exercices pelviens et éviter de soulever des charges lourdes."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le prolapsus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affaiblir les tissus et augmenter le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les grossesses multiples augmentent-elles le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les grossesses multiples peuvent affaiblir les muscles pelviens et favoriser le prolapsus."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le prolapsus ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de prolapsus augmente avec l'âge en raison de la perte de tonus musculaire."
}
},
{
"@type": "Question",
"name": "Les activités physiques peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités comme le yoga peuvent renforcer le plancher pelvien et prévenir le prolapsus."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le prolapsus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des exercices de renforcement, des pessaires et la chirurgie."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée lorsque les symptômes sont sévères et ne répondent pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Les pessaires sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les pessaires peuvent soutenir les organes et soulager les symptômes sans chirurgie."
}
},
{
"@type": "Question",
"name": "Quels exercices aident à traiter le prolapsus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les exercices de Kegel renforcent les muscles pelviens et peuvent aider à réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements médicaux non chirurgicaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements comme la physiothérapie pelvienne peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un prolapsus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'incontinence, des infections urinaires et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il entraîner des problèmes psychologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut causer de l'anxiété, de la dépression et affecter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le prolapsus peut récidiver même après un traitement chirurgical ou non chirurgical."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées au prolapsus ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les prolapsus peuvent augmenter le risque d'infections urinaires et vaginales."
}
},
{
"@type": "Question",
"name": "Le prolapsus peut-il affecter la fonction intestinale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des problèmes de constipation et de défécation difficile."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du prolapsus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'accouchement, l'obésité, le vieillissement et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le prolapsus ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et le surpoids augmentent le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les antécédents chirurgicaux sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions chirurgicales pelviennes antérieures peuvent augmenter le risque de prolapsus."
}
},
{
"@type": "Question",
"name": "Les troubles du collagène sont-ils liés au prolapsus ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du collagène peuvent affaiblir les tissus de soutien et favoriser le prolapsus."
}
},
{
"@type": "Question",
"name": "Le stress physique a-t-il un impact ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des efforts répétés ou un stress physique excessif peuvent contribuer au prolapsus."
}
}
]
}
]
}
Single-tablet regimen (STR) provides a convenient once-daily regimen for the prevention of human immunodeficiency virus (HIV) infection. Here, we investigated the safety and tolerability of coformulat...
This was a prospective, open-label, single-arm trial conducted in a sexually transmitted diseases and acquired immunodeficiency syndrome clinic of a tertiary hospital in Beijing, China. Adults requiri...
Of 112 participants enrolled in the study, 109 (97.3%) were male and the mean age was 30 ± 8 years. PEP completion was 96.4% (95% confidence interval: 91.1-99.0%). Two participants stopped PEP after 2...
A once daily, STR of BIC/FTC/TAF used as PEP was safe and well-tolerated with a high rate of completion and adherence in Chinese. BIC/FTC/TAF may be a good option for PEP....
ChiCTR.org.cn, ChiCTR2100048080....
Nonoccupational post-exposure prophylaxis (NPEP) is a short course of medication taken to reduce the likelihood of acquiring human immunodeficiency virus (HIV) infection upon exposure. A review of the...
Semi-structured interviews, focus groups, and a cross-sectional survey with a sample of 419 MSM was conducted in 2018 in China to develop and psychometrically evaluate the new instrument, the NPEP Kno...
The NPEP Knowledge Scale demonstrated excellent reliability and validity. Cronbach's alpha was 0.903. The range of item R...
The NPEP Knowledge Scale is suitable for research, program evaluation, and clinical and community services that require using NPEP to minimize the ever-present risk of new HIV infections....
This study aims to assess HIV self-testing (HIVST), pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) uptake and associations of three HIV prevention strategies among men who have se...
This study included two stages, baseline and follow-up, and was conducted in Harbin, the capital city of Heilongjiang province in North China. MSM were recruited online and by peer-referral. Data cont...
Between January 2018 and March 2019, the research team enrolled 773 MSM for baseline analysis, and 699 were HIV negative at baseline. For follow-up, 62% (430/699) participants were retained. At baseli...
Knowledge dissemination increased participant awareness and acceptance of PrEP and PEP effectively. Uptake of HIVST, PrEP, and PEP were low and associated with each other. It is promising to achieve h...
Non-occupational Post-Exposure Prophylaxis (nPEP) is an effective HIV prevention strategy in gay and bisexual men (GBM) taken after possible exposure. HIV Pre-Exposure Prophylaxis (PrEP) is also a hig...
A retrospective audit of medical records of GBM presenting to a sexual health centre and provided with nPEP compared two periods to determine if nPEP usage changed following availability of PrEP. In t...
There were 232 GBM provided with nPEP in P1, and 202 in P2. A two-population test of proportions demonstrated that GBM presentations for nPEP decreased significantly from 302/4779 (6.3%) of GBM visits...
GBM accessing nPEP decreased with statistical significance post introduction of PBS PrEP....
The effectiveness of post-exposure prophylaxis (PEP) depends on participants adherence, making it crucial to assess and compare regimen options to enhance human immunodeficiency virus (HIV) prophylaxi...
In this single-center, prospective, open-label cohort study, we included 179 participants from May 2022 to March 2023 and analyzed the differences in the 28-day medication completion rate, adherence, ...
The PEP completion rate and adherence were higher in the BIC/FTC/TAF group than in the TDF/FTC + DTG group (completion rate: 97.8% vs. 82.6%, P = 0.009; adherence: 99.6 ± 2.82% vs. 90.2 ± 25.29%, P = ...
BIC/FTC/TAF and TDF/FTC + DTG have good safety and tolerance as PEP regimens. BIC/FTC/TAF has a higher completion rate and increased adherence, thus, is recommended as a PEP regimen. These findings em...
The study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2200059994(2022-05-14), https://www.chictr.org.cn/bin/project/edit?pid=167391 )....
Health care professionals including dental staff are at greater risk of occupational exposure to life threatened blood-borne pathogens. Occupational exposures will continue to occur despite improved t...
This cross-sectional study was conducted among 404 dental students in the fifth year at a private Egyptian university from July 2019 to March 2020. Data were collected using self-administrated questio...
Our study showed that the total mean knowledge score was (0.45 ± 0.50), for attitude (0.70 ± 0.46), and that for practice (0.45 ± 0.50). There was no gender difference regarding PEP (P > 0.05). A tota...
Knowledge and practice of fifth year dental students at a private Egyptian university toward post exposure prophylaxis are not satisfactory. Awareness and curriculum modifications are important regard...
The use of non-occupational post-exposure prophylaxis (nPEP) to prevent HIV acquisition among those exposed as an approach to HIV prevention has expanded in Uganda. Although there are increased effort...
A cross-sectional study among adults was carried out from October 2020 to January 2021 in Ggulwe parish, Bussi sub-county, Wakiso district, to examine the usage of nPEP and factors influencing the usa...
Overall, 248 fisherfolk encountered an event that required the use of nPEP, and of these, 55/248 (22.2%) were able to use nPEP to prevent them from acquiring HIV. The usage of nPEP among adults in the...
The usage of nPEP among fisherfolk was low (22.2%). The low usage of nPEP was associated with a lack of knowledge and awareness about nPEP. This effort to improve the usage of nPEP should include comm...
Lopinavir/ritonavir (LPV/r) is a drug traditionally used for the treatment of HIV that has been repurposed as a potential post-exposure prophylaxis agent against COVID-19 in the COronavirus Post-Expos...
We built a popPK model on 105 LPV concentrations measured in 105 HIV-negative COPEP individuals exposed to SARS-CoV-2, complemented with 170 LPV concentrations from 119 PLWH followed in our routine th...
A one-compartment model with linear absorption and elimination best described LPV concentrations in both our analysis and in the majority of the identified studies. Globally, similar PK parameters wer...
Our analysis indicated that LPV circulating concentrations were similar between COPEP participants and PLWH, and that published popPK models described our data in a comparable way....
Post-exposure prophylaxis (PEP) for pertussis is recommended for household contacts of pertussis cases in the United States within 21 days of exposure, but data on PEP effectiveness for prevention of ...
Culture- or PCR-confirmed pertussis cases were identified through surveillance. Household contacts were interviewed within 7 days of case report and again 14-21 days later. Interviewers collected info...
Of 299 household contacts who completed both interviews, 12 (4%) reported not receiving PEP. There was no evidence of higher prevalence of cough or pertussis symptoms among contacts who did not receiv...
Very high PEP uptake was observed among household contacts of pertussis patients. Although the number of contacts who did not receive PEP was small, there was no difference in prevalence of pertussis ...
To analyze HIV Post-Exposure Prophylaxis (PEP) prescription and return for follow-up appointments....
This was a descriptive cross-sectional study using data on people who sought PEP in emergency care units (UPAs) and specialized medical services in Salvador, BA, Brazil, between January-December/2018....
Of the 1,525 people who sought PEP at UPAs, 1,273 (83.5%) met PEP eligibility criteria, while 252 (16.5%) did not; of the eligible group, 1,166 (91.6%) had antiretrovirals prescribed, while 107 (8.4%)...
We found a significant proportion of eligible users who did not have PEP prescribed at UPAs and a significant loss of return for specialized service follow-up appointments....
